{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:14:04Z","timestamp":1776867244967,"version":"3.51.2"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008965","name":"Takahashi Industrial and Economic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012036","name":"Lotte Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22gm6710007h0001"],"award-info":[{"award-number":["22gm6710007h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017349","name":"Rotary Yoneyama Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020963","name":"Japan Science and Technology Agency Moonshot Research and Development Program","doi-asserted-by":"publisher","award":["JPMJMS2021"],"award-info":[{"award-number":["JPMJMS2021"]}],"id":[{"id":"10.13039\/501100020963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020051","name":"Tamura Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K20655"],"award-info":[{"award-number":["20K20655"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2145"],"award-info":[{"award-number":["JPMJSP2145"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008695","name":"Japan Foundation for Applied Enzymology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bbrc.2022.10.072","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T11:57:56Z","timestamp":1666353476000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P1","title":["Loss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease"],"prefix":"10.1016","volume":"636","author":[{"given":"Tooba","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allah","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-4265","authenticated-orcid":false,"given":"Keisuke","family":"Yaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Hikosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6975-2962","authenticated-orcid":false,"given":"Michihiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5539-7605","authenticated-orcid":false,"given":"Takashi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.10.072_bib1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies: obesity and non-alcoholic fatty liver disease","volume":"17","author":"Li","year":"2016","journal-title":"Obes. Rev."},{"key":"10.1016\/j.bbrc.2022.10.072_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jhep.2012.07.028","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study","volume":"57","author":"Koehler","year":"2012","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2022.10.072_bib3","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis: dulai et\u00a0al","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2022.10.072_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes: HEPATOLOGY","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2022.10.072_bib5","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2022.10.072_bib6","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2022.10.072_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hep.24097","article-title":"Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease","volume":"53","author":"Ayonrinde","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2022.10.072_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.bbrc.2022.10.072_bib9","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art","volume":"22","author":"Mantovani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2022.10.072_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2018.05.006","article-title":"NAD metabolism: implications in aging and longevity","volume":"47","author":"Yaku","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbrc.2022.10.072_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","article-title":"NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus","volume":"22","author":"Cant\u00f3","year":"2015","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2022.10.072_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12929-019-0527-8","article-title":"Implications of altered NAD metabolism in metabolic disorders","volume":"26","author":"Okabe","year":"2019","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.bbrc.2022.10.072_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","article-title":"Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice","volume":"14","author":"Yoshino","year":"2011","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2022.10.072_bib14","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.7568","article-title":"Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice","volume":"7","author":"Han","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.bbrc.2022.10.072_bib15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity","volume":"15","author":"Cant\u00f3","year":"2012","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2022.10.072_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","article-title":"SIRT1 and other sirtuins in metabolism","volume":"25","author":"Chang","year":"2014","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.bbrc.2022.10.072_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-5793(01)02180-9","article-title":"Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis","volume":"492","author":"Schweiger","year":"2001","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.bbrc.2022.10.072_bib18","doi-asserted-by":"crossref","first-page":"13503","DOI":"10.1074\/jbc.M300073200","article-title":"Structural characterization of a human cytosolic NMN\/NaMN adenylyltransferase and implication in human NAD biosynthesis","volume":"278","author":"Zhang","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.10.072_bib19","doi-asserted-by":"crossref","first-page":"36334","DOI":"10.1074\/jbc.M508660200","article-title":"Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms","volume":"280","author":"Berger","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.10.072_bib20","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1111\/j.1742-4658.2011.08193.x","article-title":"Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration: NMNAT1 gene inactivation and axon degeneration","volume":"278","author":"Conforti","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2022.10.072_bib21","doi-asserted-by":"crossref","first-page":"20408","DOI":"10.1074\/jbc.M109.016469","article-title":"Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters","volume":"284","author":"Zhang","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.10.072_bib22","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1073\/pnas.0609211104","article-title":"Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1","volume":"104","author":"Berger","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2022.10.072_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/07853890.2010.547211","article-title":"Sirtuin 1 in lipid metabolism and obesity","volume":"43","author":"Schug","year":"2011","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbrc.2022.10.072_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","article-title":"Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo 1 in liver","volume":"6","author":"Matsumoto","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2022.10.072_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49547-6","article-title":"Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD)","volume":"9","author":"Yaku","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.10.072_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/BJ20100791","article-title":"Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation","volume":"433","author":"Kendrick","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2022.10.072_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep26933","article-title":"Nicotinamide riboside opposes type 2 diabetes and neuropathy in mice","volume":"6","author":"Trammell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.10.072_bib28","doi-asserted-by":"crossref","first-page":"33649","DOI":"10.18632\/oncotarget.9259","article-title":"IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2022.10.072_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/cpmo.3","article-title":"An overview of mouse models of nonalcoholic steatohepatitis: from past to present","volume":"6","author":"Jacobs","year":"2016","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.bbrc.2022.10.072_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101388","article-title":"Hepatocyte-specific perturbation of NAD+ biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis\u2013like phenotypes","volume":"297","author":"Dall","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.10.072_bib31","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.26594","article-title":"High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase: Hepatology","volume":"58","author":"Ishimoto","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2022.10.072_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048801","article-title":"Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver","volume":"7","author":"Lanaspa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2022.10.072_bib33","doi-asserted-by":"crossref","first-page":"13304","DOI":"10.1074\/jbc.RA118.006756","article-title":"Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity","volume":"294","author":"Dall","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.10.072_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s42826-019-0016-y","article-title":"Comparative study of liver injury induced by high-fat methionine- and choline-deficient diet in ICR mice originating from three different sources","volume":"35","author":"Lee","year":"2019","journal-title":"Laboratory Animal Lab. Anim. Res."},{"key":"10.1016\/j.bbrc.2022.10.072_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1590\/S0004-28032011000100015","article-title":"Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis","volume":"48","author":"Marcolin","year":"2011","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.bbrc.2022.10.072_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.yexcr.2011.11.005","article-title":"A\u00a0methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation","volume":"318","author":"Pelz","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2022.10.072_bib37","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis","volume":"285","author":"Caballero","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.10.072_bib38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jama.286.10.1195","article-title":"The continuing epidemics of obesity and diabetes in the United States","volume":"286","author":"Mokdad","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2022.10.072_bib39","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2169\/internalmedicine.53.1580","article-title":"Effects of age on insulin resistance and secretion in subjects without diabetes","volume":"53","author":"Oya","year":"2014","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbrc.2022.10.072_bib40","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1523\/JNEUROSCI.1189-10.2010","article-title":"Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in\u00a0vivo","volume":"30","author":"Babetto","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2022.10.072_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19749","article-title":"NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion","volume":"5","author":"Sasaki","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.bbrc.2022.10.072_bib42","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1523\/JNEUROSCI.1429-09.2009","article-title":"Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration in\u00a0vivo","volume":"29","author":"Sasaki","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2022.10.072_bib43","doi-asserted-by":"crossref","first-page":"19054","DOI":"10.1073\/pnas.1107325108","article-title":"Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death","volume":"108","author":"Verghese","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2022.10.072_bib44","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.1098014","article-title":"Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration","volume":"305","author":"Araki","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.10.072_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf3895","article-title":"Nuclear NAD + homeostasis governed by NMNAT1 prevents apoptosis of acute myeloid leukemia stem cells","volume":"7","author":"Shi","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbrc.2022.10.072_bib46","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/cancers12051180","article-title":"Targeting nuclear NAD+ synthesis inhibits DNA repair, impairs metabolic adaptation and increases chemosensitivity of U-2OS osteosarcoma cells","volume":"12","author":"Kiss","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2022.10.072_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147037","article-title":"Nmnat3 is dispensable in mitochondrial NAD level maintenance in\u00a0vivo","volume":"11","author":"Yamamoto","year":"2016","journal-title":"PLoS One"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22014747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22014747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:44:49Z","timestamp":1762094689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22014747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":47,"alternative-id":["S0006291X22014747"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.10.072","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of hepatic Nmnat1 has no impact on diet-induced fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.10.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}